| Individual intestinal symbionts induce a distinct population of RORγ+ regulatory T cells E Sefik, N Geva-Zatorsky, S Oh, L Konnikova, D Zemmour, AM McGuire, ... Science 349 (6251), 993-997, 2015 | 840 | 2015 |
| Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages JL Guerriero, A Sotayo, HE Ponichtera, JA Castrillon, AL Pourzia, ... Nature 543 (7645), 428-432, 2017 | 482 | 2017 |
| Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group M Lobera, KP Madauss, DT Pohlhaus, QG Wright, M Trocha, DR Schmidt, ... Nature chemical biology 9 (5), 319-325, 2013 | 364 | 2013 |
| Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms S Xiao, N Yosef, J Yang, Y Wang, L Zhou, C Zhu, C Wu, E Baloglu, ... Immunity 40 (4), 477-489, 2014 | 310 | 2014 |
| Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo J Skepner, R Ramesh, M Trocha, D Schmidt, E Baloglu, M Lobera, ... The Journal of Immunology 192 (6), 2564-2575, 2014 | 185 | 2014 |
| An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition E Forcade, K Paz, R Flynn, B Griesenauer, T Amet, W Li, L Liu, ... JCI insight 2 (12), 2017 | 67 | 2017 |
| Synthesis of 2, 3-dihydro-3-hydroxy-2-hydroxylalkylbenzofurans from epoxy aldehydes. One-step syntheses of brosimacutin G, vaginidiol, vaginol, smyrindiol, xanthoarnol, and … Y Zou, M Lobera, BB Snider The Journal of Organic Chemistry 70 (5), 1761-1770, 2005 | 55 | 2005 |
| S1P receptor modulating compounds and use thereof AK Saha, N Schutz, X Yu, D McCauley, M Lobera, Y Marantz, J Lin, ... US Patent 7,855,193, 2010 | 45 | 2010 |
| Improved syntheses of the naturally occurring glycosidase inhibitor salacinol A Ghavami, KS Sadalapure, BD Johnston, M Lobera, BB Snider, BM Pinto Synlett 2003 (09), 1259-1262, 2003 | 42 | 2003 |
| Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MS AK Saha, X Yu, J Lin, M Lobera, A Sharadendu, S Chereku, N Schutz, ... ACS Medicinal Chemistry Letters 2 (2), 97-101, 2011 | 39 | 2011 |
| S1P receptor modulating compounds and use thereof R Burli, VJ Cee, J Golden, BA Lanman, S Neira, A Saha, N Schutz, X Yu, ... US Patent 7,919,519, 2011 | 30 | 2011 |
| Compounds and methods E Baloglu, S Ghosh, M Lobera, D Schmidt US Patent 8,901,156, 2014 | 29* | 2014 |
| From RORγt agonist to two types of RORγt inverse agonists Y Wang, W Cai, T Tang, Q Liu, T Yang, L Yang, Y Ma, G Zhang, Y Huang, ... ACS Medicinal Chemistry Letters 9 (2), 120-124, 2018 | 28 | 2018 |
| Substituted arylamine compounds and methods of treatment O Becker, R Melendez, Y Marantz, A Sharadendu, M Fichman, M Lobera, ... US Patent 7,968,538, 2011 | 26 | 2011 |
| Discovery of a Potent, S1P3-Sparing Benzothiazole Agonist of Sphingosine-1-Phosphate Receptor 1 (S1P1) BA Lanman, VJ Cee, SR Cheruku, M Frohn, J Golden, J Lin, M Lobera, ... ACS Medicinal Chemistry Letters 2 (2), 102-106, 2011 | 26 | 2011 |
| Synthesis of the tetracyclic core of the bisabosquals BB Snider, M Lobera Tetrahedron letters 45 (26), 5015-5018, 2004 | 24 | 2004 |
| In vivo regulation of gene expression and T helper type 17 differentiation by RORγt inverse agonists J Skepner, M Trocha, R Ramesh, XA Qu, D Schmidt, E Baloglu, M Lobera, ... Immunology 145 (3), 347-356, 2015 | 22 | 2015 |
| Synthesis of the alkenyl-substituted tetracyclic core of the bisabosquals J Zhou, M Lobera, BJ Neubert-Langille, BB Snider Tetrahedron 63 (40), 10018-10024, 2007 | 20 | 2007 |
| Thienopyridinone compounds and methods of treatment DS Dhanoa, O Becker, S Noiman, L Wu, M Lobera, P Mohanty, Y Marantz, ... US Patent 7,407,966, 2008 | 16 | 2008 |
| TMP778, a selective inhibitor of RORγt, suppresses experimental autoimmune uveitis development, but affects both Th17 and Th1 cell populations C Lyu, SJ Bing, WS Wandu, B Xu, G Shi, SJ Hinshaw, M Lobera, ... European journal of immunology 48 (11), 1810-1816, 2018 | 15 | 2018 |
